AU2001292093A1 - Retroviral vectors containing internal ribosomal entry sites - Google Patents
Retroviral vectors containing internal ribosomal entry sitesInfo
- Publication number
- AU2001292093A1 AU2001292093A1 AU2001292093A AU9209301A AU2001292093A1 AU 2001292093 A1 AU2001292093 A1 AU 2001292093A1 AU 2001292093 A AU2001292093 A AU 2001292093A AU 9209301 A AU9209301 A AU 9209301A AU 2001292093 A1 AU2001292093 A1 AU 2001292093A1
- Authority
- AU
- Australia
- Prior art keywords
- vectors containing
- retroviral vectors
- entry sites
- containing internal
- ribosomal entry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000013598 vector Substances 0.000 title abstract 6
- 230000001177 retroviral effect Effects 0.000 title abstract 3
- 210000003705 ribosome Anatomy 0.000 title 1
- -1 Aromatic Amino Acid Chemical class 0.000 abstract 1
- 102100038238 Aromatic-L-amino-acid decarboxylase Human genes 0.000 abstract 1
- 102000036509 GTP Cyclohydrolase Human genes 0.000 abstract 1
- 108010023555 GTP Cyclohydrolase Proteins 0.000 abstract 1
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 abstract 1
- 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 abstract 1
- 102000048218 Tyrosine 3-monooxygenases Human genes 0.000 abstract 1
- 108010035075 Tyrosine decarboxylase Proteins 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/48—Vector systems having a special element relevant for transcription regulating transport or export of RNA, e.g. RRE, PRE, WPRE, CTE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
- C12N2840/206—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES having multiple IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Molds, Cores, And Manufacturing Methods Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0024550.6 | 2000-10-06 | ||
GBGB0024550.6A GB0024550D0 (enrdf_load_stackoverflow) | 2000-10-06 | 2000-10-06 | |
PCT/GB2001/004433 WO2002029065A2 (en) | 2000-10-06 | 2001-10-05 | Retroviral vectors containing internal ribosomal entry sites |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001292093A1 true AU2001292093A1 (en) | 2002-04-15 |
Family
ID=9900826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001292093A Abandoned AU2001292093A1 (en) | 2000-10-06 | 2001-10-05 | Retroviral vectors containing internal ribosomal entry sites |
Country Status (13)
Families Citing this family (130)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7588757B2 (en) * | 2001-03-14 | 2009-09-15 | Genzyme Corporation | Methods of treating Parkinson's disease using recombinant adeno-associated virus virions |
ES2411981T3 (es) * | 2002-02-01 | 2013-07-09 | Oxford Biomedica (Uk) Limited | Vector lentivírico |
EP2078040B1 (en) * | 2006-11-02 | 2017-06-28 | Daniel J. Capon | Methods of producing hybrid polypeptides with moving parts |
JP5615271B2 (ja) | 2008-06-18 | 2014-10-29 | オックスフォード バイオメディカ(ユーケー)リミテッド | ウイルス精製法 |
US8829173B2 (en) * | 2008-09-26 | 2014-09-09 | Tocagen Inc. | Recombinant vectors |
WO2010055290A1 (en) * | 2008-11-11 | 2010-05-20 | Oxford Biomedica (Uk) Limited | Method |
CN102695526A (zh) * | 2009-11-09 | 2012-09-26 | 吉恩波多治疗股份公司 | 用于神经元特异性的体内连续dopa合成的新型病毒载体构建体 |
JP5965392B2 (ja) * | 2010-05-28 | 2016-08-03 | オックスフォード バイオメディカ (ユーケー) リミテッド | 脳へのレンチウイルスベクターの送達 |
WO2012135389A2 (en) * | 2011-03-28 | 2012-10-04 | The Regents Of The University Of California | Host cells and methods for oxidizing aromatic amino acids |
US20130189754A1 (en) | 2011-09-12 | 2013-07-25 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
JP6698114B2 (ja) * | 2011-10-28 | 2020-05-27 | オックスフォード バイオメディカ (ユーケー) リミテッド | 構築物 |
GB201118636D0 (en) | 2011-10-28 | 2011-12-07 | Oxford Biomedica Ltd | Nucleotide sequence |
US10400252B2 (en) | 2011-10-28 | 2019-09-03 | Oxford Biomedica (Uk) Ltd. | Catecholamine enzyme fusions |
US9347065B2 (en) | 2012-03-29 | 2016-05-24 | International Aids Vaccine Initiative | Methods to improve vector expression and genetic stability |
EP2848687B1 (en) | 2012-04-27 | 2017-09-13 | JCR Pharmaceuticals Co., Ltd. | Novel expression vector |
WO2014043131A1 (en) * | 2012-09-14 | 2014-03-20 | The Regents Of The University Of California | Lentiviral vector for stem cell gene therapy of sickle cell disease |
US11065311B2 (en) | 2012-10-25 | 2021-07-20 | Denovo Biopharma Llc | Retroviral vector with mini-promoter cassette |
SG11201504523UA (en) | 2012-12-12 | 2015-07-30 | Broad Inst Inc | Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications |
WO2014093701A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof |
WO2014093965A1 (en) | 2012-12-14 | 2014-06-19 | Case Western Reserve University | Genomic rna packaging enhancer element |
CN105793425B (zh) | 2013-06-17 | 2021-10-26 | 布罗德研究所有限公司 | 使用病毒组分靶向障碍和疾病的crispr-cas系统和组合物的递送、用途和治疗应用 |
JP6738729B2 (ja) | 2013-06-17 | 2020-08-12 | ザ・ブロード・インスティテュート・インコーポレイテッド | 分裂終了細胞の疾患および障害をターゲティングおよびモデリングするための系、方法および組成物の送達、エンジニアリングおよび最適化 |
MX2015017312A (es) | 2013-06-17 | 2017-04-10 | Broad Inst Inc | Suministro y uso de composiciones, vectores y sistemas crispr-cas para la modificación dirigida y terapia hepáticas. |
WO2015048690A1 (en) * | 2013-09-27 | 2015-04-02 | The Regents Of The University Of California | Optimized small guide rnas and methods of use |
US10801070B2 (en) | 2013-11-25 | 2020-10-13 | The Broad Institute, Inc. | Compositions and methods for diagnosing, evaluating and treating cancer |
US11725237B2 (en) | 2013-12-05 | 2023-08-15 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
WO2015089473A1 (en) | 2013-12-12 | 2015-06-18 | The Broad Institute Inc. | Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation |
JP6793547B2 (ja) | 2013-12-12 | 2020-12-02 | ザ・ブロード・インスティテュート・インコーポレイテッド | 最適化機能CRISPR−Cas系による配列操作のための系、方法および組成物 |
KR20160089530A (ko) | 2013-12-12 | 2016-07-27 | 더 브로드 인스티튜트, 인코퍼레이티드 | Hbv 및 바이러스 질병 및 질환을 위한 crisprcas 시스템 및 조성물의 전달,용도 및 치료적 적용 |
CN106061510B (zh) | 2013-12-12 | 2020-02-14 | 布罗德研究所有限公司 | 用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用 |
AU2014362248A1 (en) | 2013-12-12 | 2016-06-16 | Massachusetts Institute Of Technology | Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disorders |
US11452768B2 (en) | 2013-12-20 | 2022-09-27 | The Broad Institute, Inc. | Combination therapy with neoantigen vaccine |
WO2016028682A1 (en) | 2014-08-17 | 2016-02-25 | The Broad Institute Inc. | Genome editing using cas9 nickases |
WO2016049163A2 (en) | 2014-09-24 | 2016-03-31 | The Broad Institute Inc. | Use and production of chd8+/- transgenic animals with behavioral phenotypes characteristic of autism spectrum disorder |
WO2016049258A2 (en) | 2014-09-25 | 2016-03-31 | The Broad Institute Inc. | Functional screening with optimized functional crispr-cas systems |
EP3212788A2 (en) | 2014-10-27 | 2017-09-06 | The Broad Institute, Inc. | Compositions, methods and use of synthetic lethal screening |
JP6401871B2 (ja) | 2014-11-05 | 2018-10-10 | ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. | パーキンソン病の治療のためのaadcポリヌクレオチド |
RU2749882C2 (ru) | 2014-11-14 | 2021-06-18 | Вояджер Терапьютикс, Инк. | Модулирующие полинуклеотиды |
EP3230452B1 (en) | 2014-12-12 | 2025-06-11 | The Broad Institute, Inc. | Dead guides for crispr transcription factors |
EP3889260A1 (en) | 2014-12-12 | 2021-10-06 | The Broad Institute, Inc. | Protected guide rnas (pgrnas) |
WO2016094880A1 (en) | 2014-12-12 | 2016-06-16 | The Broad Institute Inc. | Delivery, use and therapeutic applications of crispr systems and compositions for genome editing as to hematopoietic stem cells (hscs) |
WO2016094874A1 (en) | 2014-12-12 | 2016-06-16 | The Broad Institute Inc. | Escorted and functionalized guides for crispr-cas systems |
EP3234192B1 (en) | 2014-12-19 | 2021-07-14 | The Broad Institute, Inc. | Unbiased identification of double-strand breaks and genomic rearrangement by genome-wide insert capture sequencing |
WO2016100975A1 (en) | 2014-12-19 | 2016-06-23 | Massachsetts Institute Ot Technology | Molecular biomarkers for cancer immunotherapy |
EP3234130B1 (en) | 2014-12-19 | 2020-11-25 | The Broad Institute, Inc. | Methods for profiling the t-cell- receptor repertoire |
WO2016106236A1 (en) | 2014-12-23 | 2016-06-30 | The Broad Institute Inc. | Rna-targeting system |
CA2970370A1 (en) | 2014-12-24 | 2016-06-30 | Massachusetts Institute Of Technology | Crispr having or associated with destabilization domains |
ES2578903B1 (es) * | 2015-01-02 | 2017-07-07 | Instituto De Salud Carlos Iii | Vector lentiviral de expresión autolimitada |
EP3268044A2 (en) | 2015-03-11 | 2018-01-17 | The Broad Institute Inc. | Prmt5 inhibitors for the treatment of cancer with reduced mtap activty |
JP6913032B2 (ja) | 2015-05-20 | 2021-08-04 | ザ・ブロード・インスティテュート・インコーポレイテッド | 共通ネオ抗原 |
US20180355033A1 (en) | 2015-06-10 | 2018-12-13 | Dana-Farber Cancer Institute, Inc. | Antibodies, compounds and screens for identifying and treating cachexia or pre-cachexia |
CN108290933A (zh) | 2015-06-18 | 2018-07-17 | 布罗德研究所有限公司 | 降低脱靶效应的crispr酶突变 |
WO2016205745A2 (en) * | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Cell sorting |
CA3012631A1 (en) | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Novel crispr enzymes and systems |
US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
WO2016205749A1 (en) | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Novel crispr enzymes and systems |
JP2018522595A (ja) * | 2015-08-03 | 2018-08-16 | ミョドパ・リミテッド | L−dopaの全身合成及び調節 |
US11214800B2 (en) | 2015-08-18 | 2022-01-04 | The Broad Institute, Inc. | Methods and compositions for altering function and structure of chromatin loops and/or domains |
WO2017069958A2 (en) | 2015-10-09 | 2017-04-27 | The Brigham And Women's Hospital, Inc. | Modulation of novel immune checkpoint targets |
EP3365441A1 (en) | 2015-10-22 | 2018-08-29 | The Broad Institute Inc. | Type vi-b crispr enzymes and systems |
EP3368687B1 (en) | 2015-10-27 | 2021-09-29 | The Broad Institute, Inc. | Compositions and methods for targeting cancer-specific sequence variations |
WO2017075465A1 (en) | 2015-10-28 | 2017-05-04 | The Broad Institute Inc. | Compositions and methods for evaluating and modulating immune responses by detecting and targeting gata3 |
WO2017075451A1 (en) | 2015-10-28 | 2017-05-04 | The Broad Institute Inc. | Compositions and methods for evaluating and modulating immune responses by detecting and targeting pou2af1 |
WO2017075478A2 (en) | 2015-10-28 | 2017-05-04 | The Broad Institute Inc. | Compositions and methods for evaluating and modulating immune responses by use of immune cell gene signatures |
WO2017106657A1 (en) | 2015-12-18 | 2017-06-22 | The Broad Institute Inc. | Novel crispr enzymes and systems |
WO2017180587A2 (en) | 2016-04-11 | 2017-10-19 | Obsidian Therapeutics, Inc. | Regulated biocircuit systems |
US20190346442A1 (en) | 2016-04-18 | 2019-11-14 | The Broad Institute, Inc. | Improved hla epitope prediction |
CA3026112A1 (en) | 2016-04-19 | 2017-10-26 | The Broad Institute, Inc. | Cpf1 complexes with reduced indel activity |
EP3445848A1 (en) | 2016-04-19 | 2019-02-27 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
WO2017189308A1 (en) | 2016-04-19 | 2017-11-02 | The Broad Institute Inc. | Novel crispr enzymes and systems |
DK3445406T3 (da) * | 2016-04-20 | 2021-08-30 | Centro De Investig Energeticas Medioambientales Y Tecnologicas O A M P | Sammensætninger og fremgangsmåder til forøget genekspression af pklr |
JP7066635B2 (ja) | 2016-05-18 | 2022-05-13 | ボイジャー セラピューティクス インコーポレイテッド | 調節性ポリヌクレオチド |
KR20190019168A (ko) | 2016-06-17 | 2019-02-26 | 더 브로드 인스티튜트, 인코퍼레이티드 | 제vi형 crispr 오솔로그 및 시스템 |
WO2018005873A1 (en) | 2016-06-29 | 2018-01-04 | The Broad Institute Inc. | Crispr-cas systems having destabilization domain |
WO2018026827A1 (en) * | 2016-08-01 | 2018-02-08 | Health Research, Inc. | Compositions and methods for rapid cloning of t-cell receptors |
WO2018035387A1 (en) | 2016-08-17 | 2018-02-22 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
EP3500671B1 (en) | 2016-08-17 | 2024-07-10 | The Broad Institute, Inc. | Method of selecting target sequences for the design of guide rnas |
WO2018049025A2 (en) | 2016-09-07 | 2018-03-15 | The Broad Institute Inc. | Compositions and methods for evaluating and modulating immune responses |
CN110536966A (zh) * | 2016-09-08 | 2019-12-03 | 能源环境和技术研究中心O.A.,M.P. | 用于范可尼贫血患者的基因疗法 |
US20200016202A1 (en) | 2016-10-07 | 2020-01-16 | The Brigham And Women's Hospital, Inc. | Modulation of novel immune checkpoint targets |
EP3528852B1 (en) | 2016-10-20 | 2025-09-03 | Sangamo Therapeutics, Inc. | Methods and compositions for the treatment of fabry disease |
EP3574116A1 (en) | 2017-01-24 | 2019-12-04 | The Broad Institute, Inc. | Compositions and methods for detecting a mutant variant of a polynucleotide |
ES2950676T3 (es) | 2017-01-30 | 2023-10-11 | Kws Saat Se & Co Kgaa | Reparación de enlace de plantillas a endonucleasas para modificación de genes |
CN116693695A (zh) | 2017-02-12 | 2023-09-05 | 百欧恩泰美国公司 | 基于hla的方法和组合物及其用途 |
JP2020511141A (ja) | 2017-03-15 | 2020-04-16 | ザ・ブロード・インスティテュート・インコーポレイテッド | 新規Cas13bオルソログCRISPR酵素及び系 |
US11840711B2 (en) | 2017-04-12 | 2023-12-12 | The Broad Institute, Inc. | Type VI CRISPR orthologs and systems |
US12350368B2 (en) | 2017-04-14 | 2025-07-08 | The Broad Institute, Inc. | Delivery of large payloads |
US11591601B2 (en) | 2017-05-05 | 2023-02-28 | The Broad Institute, Inc. | Methods for identification and modification of lncRNA associated with target genotypes and phenotypes |
WO2018213726A1 (en) | 2017-05-18 | 2018-11-22 | The Broad Institute, Inc. | Systems, methods, and compositions for targeted nucleic acid editing |
JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
CN111511388A (zh) | 2017-09-21 | 2020-08-07 | 博德研究所 | 用于靶向核酸编辑的系统、方法和组合物 |
EP3692152B1 (en) | 2017-10-04 | 2025-09-03 | The Broad Institute, Inc. | Methods and compositions for altering function and structure of chromatin loops and/or domains |
EP3697452A4 (en) | 2017-10-16 | 2021-11-24 | Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, O.A., M.P. | LENTIVIRAL VECTORS FOR THE ADMINISTRATION OF PKLR TO TREAT PYRUVATE KINASE DEFICIENCY |
US12227742B2 (en) | 2017-10-23 | 2025-02-18 | The Broad Institute, Inc. | Nucleic acid modifiers |
WO2019089803A1 (en) | 2017-10-31 | 2019-05-09 | The Broad Institute, Inc. | Methods and compositions for studying cell evolution |
US12221720B2 (en) | 2017-11-13 | 2025-02-11 | The Broad Institute, Inc. | Methods for determining spatial and temporal gene expression dynamics during adult neurogenesis in single cells |
WO2019094983A1 (en) | 2017-11-13 | 2019-05-16 | The Broad Institute, Inc. | Methods and compositions for treating cancer by targeting the clec2d-klrb1 pathway |
WO2019126709A1 (en) | 2017-12-22 | 2019-06-27 | The Broad Institute, Inc. | Cas12b systems, methods, and compositions for targeted dna base editing |
JP7197901B2 (ja) * | 2018-01-11 | 2022-12-28 | 学校法人慈恵大学 | Hunter症候群の遺伝子治療に使用されるベクタープラスミド、レンチウイルスベクターシステム、細胞、及び、細胞製剤 |
US10968257B2 (en) | 2018-04-03 | 2021-04-06 | The Broad Institute, Inc. | Target recognition motifs and uses thereof |
AU2019261646A1 (en) | 2018-04-27 | 2020-11-12 | Spacecraft Seven, Llc | Gene therapy for CNS degeneration |
AU2019268330A1 (en) | 2018-05-15 | 2020-11-26 | Voyager Therapeutics, Inc. | Compositions and methods for the treatment of Parkinson's disease |
CN108841868A (zh) * | 2018-05-31 | 2018-11-20 | 康霖生物科技(杭州)有限公司 | 一种用于中枢神经系统疾病治疗的基因序列构建体 |
US20210163944A1 (en) | 2018-08-07 | 2021-06-03 | The Broad Institute, Inc. | Novel cas12b enzymes and systems |
WO2020041380A1 (en) | 2018-08-20 | 2020-02-27 | The Broad Institute, Inc. | Methods and compositions for optochemical control of crispr-cas9 |
WO2020072700A1 (en) | 2018-10-02 | 2020-04-09 | Dana-Farber Cancer Institute, Inc. | Hla single allele lines |
WO2020131586A2 (en) | 2018-12-17 | 2020-06-25 | The Broad Institute, Inc. | Methods for identifying neoantigens |
US11384344B2 (en) | 2018-12-17 | 2022-07-12 | The Broad Institute, Inc. | CRISPR-associated transposase systems and methods of use thereof |
JP7236543B2 (ja) | 2018-12-21 | 2023-03-09 | ビオンテック ユーエス インコーポレイテッド | Hlaクラスii特異的エピトープの予測およびcd4+ t細胞の特徴付けのための方法およびシステム |
CN113423419A (zh) * | 2019-01-04 | 2021-09-21 | 桑格摩生物治疗股份有限公司 | 用于治疗法布里病的方法和组合物 |
US12215382B2 (en) | 2019-03-01 | 2025-02-04 | The General Hospital Corporation | Liver protective MARC variants and uses thereof |
CN115835887A (zh) | 2019-03-10 | 2023-03-21 | 牛津生物医学(英国)有限公司 | 用于治疗帕金森病的基因治疗组合物和方法 |
WO2020191102A1 (en) | 2019-03-18 | 2020-09-24 | The Broad Institute, Inc. | Type vii crispr proteins and systems |
US20220220469A1 (en) | 2019-05-20 | 2022-07-14 | The Broad Institute, Inc. | Non-class i multi-component nucleic acid targeting systems |
JP2022544688A (ja) | 2019-08-16 | 2022-10-20 | マサチューセッツ インスティテュート オブ テクノロジー | Crispr/cas13を使用する標的化トランススプライシング |
US12297426B2 (en) | 2019-10-01 | 2025-05-13 | The Broad Institute, Inc. | DNA damage response signature guided rational design of CRISPR-based systems and therapies |
US12394502B2 (en) | 2019-10-02 | 2025-08-19 | The General Hospital Corporation | Method for predicting HLA-binding peptides using protein structural features |
DE102020111571A1 (de) * | 2020-03-11 | 2021-09-16 | Immatics US, Inc. | Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren |
AU2021320902A1 (en) | 2020-08-07 | 2023-04-06 | Spacecraft Seven, Llc | Plakophilin-2 (PKP2) gene therapy using AAV vector |
GB202013940D0 (en) | 2020-09-04 | 2020-10-21 | Synpromics Ltd | Regulatory nucleic acid sequences |
WO2022076556A2 (en) | 2020-10-07 | 2022-04-14 | Asklepios Biopharmaceutical, Inc. | Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy disorders including limb girdle 2i (lgmd2i) |
WO2022132596A2 (en) | 2020-12-14 | 2022-06-23 | Biontech Us Inc. | Tissue-specific antigens for cancer immunotherapy |
CN114107396B (zh) * | 2021-11-26 | 2024-02-02 | 和元智造(上海)基因技术有限公司 | 慢病毒载体、系统及其应用 |
EP4503923A1 (en) | 2022-04-04 | 2025-02-12 | The Regents of the University of California | Genetic complementation compositions and methods |
WO2024010067A1 (ja) * | 2022-07-08 | 2024-01-11 | Jcrファーマ株式会社 | 中枢神経系疾患の治療のための、核酸分子、ベクター、組換え細胞及び薬剤 |
WO2024015892A1 (en) | 2022-07-13 | 2024-01-18 | The Broad Institute, Inc. | Hla-ii immunopeptidome methods and systems for antigen discovery |
WO2025072383A1 (en) | 2023-09-25 | 2025-04-03 | The Broad Institute, Inc. | Viral open reading frames, uses thereof, and methods of detecting the same |
WO2025097055A2 (en) | 2023-11-02 | 2025-05-08 | The Broad Institute, Inc. | Compositions and methods of use of t cells in immunotherapy |
WO2025129158A1 (en) | 2023-12-15 | 2025-06-19 | The Broad Institute, Inc. | Engineered arc delivery vesicles and uses thereof |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5169762A (en) | 1983-03-03 | 1992-12-08 | Genentech, Inc. | Human nerve growth factor by recombinant technology |
WO1991000047A1 (en) | 1989-06-30 | 1991-01-10 | The Regents Of The University Of California | Retrovirus detection |
JPH06500923A (ja) | 1990-09-21 | 1994-01-27 | カイロン コーポレイション | パッケージング細胞 |
JPH06501617A (ja) | 1990-09-25 | 1994-02-24 | ジェネンテク,インコーポレイテッド | 新規な神経栄養因子 |
EP0598029B1 (en) | 1991-08-07 | 2002-02-27 | ANDERSON, W., French | Retroviral vectors containing internal ribosome entry sites |
JPH08510636A (ja) * | 1993-01-20 | 1996-11-12 | バイオトランスプラント,インコーポレイテッド | 多重翻訳開始部位から多量体タンパク質を発現出来るレトロウイルスベクター |
US5834256A (en) | 1993-06-11 | 1998-11-10 | Cell Genesys, Inc. | Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
US5728803A (en) | 1994-06-03 | 1998-03-17 | Genentech, Inc. | Pantropic neurotrophic factors |
US6103226A (en) * | 1994-08-12 | 2000-08-15 | Arch Development Corporation | Genetically engineered cells that produce produce L. Dopa |
WO1996009400A1 (en) | 1994-09-19 | 1996-03-28 | Systemix, Inc. | Methods for genetically modifying hematopoietic stem cells |
US5739307A (en) | 1995-08-28 | 1998-04-14 | Washington University | Polynucleotide encoding neurturin neurotrophic factor |
AU7435296A (en) | 1995-10-16 | 1997-05-07 | Dana-Farber Cancer Institute | Novel expression vectors and methods of use |
CA2237000A1 (en) | 1995-11-08 | 1997-05-15 | The Whitehead Institute For Biomedical Research | Stable packaging cell line producing pseudotyped retroviruses |
WO1997018319A1 (en) | 1995-11-14 | 1997-05-22 | Somatix Therapy Corporation | Joint expression of gtp cyclohydrolase and tyrosine hydroxylase |
US6222022B1 (en) | 1996-03-14 | 2001-04-24 | Washington University | Persephin and related growth factors |
US6133027A (en) | 1996-08-07 | 2000-10-17 | City Of Hope | Inducible expression system |
US5739018A (en) | 1996-08-07 | 1998-04-14 | The Regents Of The University Of California | Packaging cell lines for pseudotyped retroviral vectors |
WO1998012338A1 (en) | 1996-09-21 | 1998-03-26 | Viromedica Pacific Limited | Improved retroviral vectors for gene therapy |
ATE198910T1 (de) * | 1996-10-17 | 2001-02-15 | Oxford Biomedica Ltd | Retrovirale vektoren |
US5969105A (en) | 1996-10-25 | 1999-10-19 | Feng; Yiqing | Stem cell factor receptor agonists |
GB9622500D0 (en) | 1996-10-29 | 1997-01-08 | Oxford Biomedica Ltd | Therapeutic gene |
JP4390860B2 (ja) * | 1997-05-13 | 2009-12-24 | ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | レンチウイルスをベースにした遺伝子転移ベクター |
US5834914A (en) | 1997-09-08 | 1998-11-10 | Safetran Systems Corporation | Railroad crossing gate mechanism control system |
US6136597A (en) * | 1997-09-18 | 2000-10-24 | The Salk Institute For Biological Studies | RNA export element |
GB9720465D0 (en) | 1997-09-25 | 1997-11-26 | Oxford Biomedica Ltd | Dual-virus vectors |
WO1999015684A2 (en) * | 1997-09-23 | 1999-04-01 | Oxford Biomedica (Uk) Limited | Expression of genes in hematopoietic stem cells in hischaemic conditions |
DK1895010T3 (da) | 1997-12-22 | 2011-11-21 | Oxford Biomedica Ltd | Vektorer baseret på virus for infektiøs hesteanæmi (eiav) |
GB2356200B (en) * | 1997-12-22 | 2002-05-01 | Oxford Biomedica Ltd | Retroviral vectors |
GB9803351D0 (en) | 1998-02-17 | 1998-04-15 | Oxford Biomedica Ltd | Anti-viral vectors |
CN1325653C (zh) | 1998-05-22 | 2007-07-11 | 牛津生物医学(英国)有限公司 | 逆转录病毒传递系统 |
US6555342B1 (en) * | 1998-06-03 | 2003-04-29 | Uab Research Foundation | Fusion protein delivery system and uses thereof |
US6958226B1 (en) * | 1998-09-11 | 2005-10-25 | The Children's Medical Center Corp. | Packaging cells comprising codon-optimized gagpol sequences and lacking lentiviral accessory proteins |
US6284540B1 (en) | 1998-09-29 | 2001-09-04 | Washington University | Artemin, a novel neurotrophic factor |
US6506378B1 (en) * | 1998-12-16 | 2003-01-14 | Arch Development Corporation | Vesicular monoamine transporter gene therapy in Parkinson's disease |
-
2000
- 2000-10-06 GB GBGB0024550.6A patent/GB0024550D0/en not_active Ceased
-
2001
- 2001-10-05 DK DK01972317.0T patent/DK1337655T3/da active
- 2001-10-05 AU AU2001292093A patent/AU2001292093A1/en not_active Abandoned
- 2001-10-05 PT PT01972317T patent/PT1337655E/pt unknown
- 2001-10-05 EP EP01972317A patent/EP1337655B1/en not_active Expired - Lifetime
- 2001-10-05 AT AT01972317T patent/ATE474058T1/de active
- 2001-10-05 EP EP09014156A patent/EP2180057A1/en not_active Withdrawn
- 2001-10-05 DE DE60142576T patent/DE60142576D1/de not_active Expired - Lifetime
- 2001-10-05 CA CA002424738A patent/CA2424738A1/en not_active Abandoned
- 2001-10-05 JP JP2002532634A patent/JP4224295B2/ja not_active Expired - Lifetime
- 2001-10-05 WO PCT/GB2001/004433 patent/WO2002029065A2/en active Application Filing
- 2001-10-05 ES ES01972317T patent/ES2348277T3/es not_active Expired - Lifetime
-
2003
- 2003-04-07 US US10/408,456 patent/US7259015B2/en not_active Expired - Lifetime
-
2006
- 2006-07-14 US US11/486,914 patent/US20070025970A1/en not_active Abandoned
-
2008
- 2008-07-07 US US12/168,563 patent/US20090111106A1/en not_active Abandoned
-
2010
- 2010-10-06 CY CY20101100888T patent/CY1110817T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2348277T3 (es) | 2010-12-02 |
GB0024550D0 (enrdf_load_stackoverflow) | 2000-11-22 |
CA2424738A1 (en) | 2002-04-11 |
US20070025970A1 (en) | 2007-02-01 |
US20090111106A1 (en) | 2009-04-30 |
PT1337655E (pt) | 2010-08-25 |
EP1337655A2 (en) | 2003-08-27 |
DK1337655T3 (da) | 2010-09-20 |
DE60142576D1 (de) | 2010-08-26 |
EP1337655B1 (en) | 2010-07-14 |
US20040013648A1 (en) | 2004-01-22 |
JP4224295B2 (ja) | 2009-02-12 |
CY1110817T1 (el) | 2015-06-10 |
WO2002029065A3 (en) | 2002-12-27 |
ATE474058T1 (de) | 2010-07-15 |
US7259015B2 (en) | 2007-08-21 |
WO2002029065A2 (en) | 2002-04-11 |
JP2004520016A (ja) | 2004-07-08 |
EP2180057A1 (en) | 2010-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001292093A1 (en) | Retroviral vectors containing internal ribosomal entry sites | |
DK1351703T3 (da) | Anvendelse af et polypeptid omfattende det ekstracellulære domæne af IL-20RA og IL-20RB til behandling af inflammation | |
AU2001252615A2 (en) | Method for attaching authentication bar code, authentication method, apparatus for attaching authentication bar code, authentication apparatus and portable terminal | |
AU2001252615A1 (en) | Method for attaching authentication bar code, authentication method, apparatus for attaching authentication bar code, authentication apparatus and portable terminal | |
WO2003008444A3 (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
EP1457558A8 (en) | Weed controller metabolism proteins, genes thereof and use of the same | |
WO2005058959A3 (en) | Treatment of viral infections | |
NO20011017D0 (no) | Polymeriserings-inhibitering av styren-monomerer | |
MXPA04012105A (es) | Metodo, sistema yterminal para recibir el contenido con acceso autorizado. | |
WO2002065993A3 (en) | Use of aryl nitrone compounds in methods for treating neuropathic pain | |
CA2296560A1 (en) | Amino acid derivatives useful to treat stroke | |
AU2001248822A1 (en) | Gd3-mimetic peptides | |
WO2003040290A3 (de) | Gene aus corynebacterium glutamicum die fuer homeostase- und adaptions-proteine codieren | |
AUPP627498A0 (en) | Novel peptides - i | |
ZA989705B (en) | Epoxide hydrolase | |
EP1762612A3 (en) | Insertion sequence elements derived from ralstonia solanacearum | |
ATE412751T1 (de) | Menschliche tak1 und für diese kodierende dna | |
WO2001048185A3 (en) | Transcription regulatory sequences derived from chlamydomonas reinhardtii | |
DK1425295T3 (da) | Modificerede peptider og deres anvendelse til behandling af autoimmune sygdomme | |
WO2002046378A3 (en) | Alternative pol k nucleotide and amino acid sequence and methods for using | |
WO2003041640A3 (en) | METHODS FOR TREATING ISCHEMIC REPERFUSION INJURY USING IkB KINASE-BETA INHIBITORS | |
Rösch | Endoscopic Ultrasonography-More Questions than Answers? | |
DK1280890T3 (da) | Mutante stammer, der er i stand til at producere kemisk differentierede proteiner ved inkorporering af ikke-traditionelle aminosyrer | |
WO2004003170A3 (en) | Agents capable of inhibiting ras and uses thereof | |
WO2001092490A3 (en) | Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |